CINAPSIS NEUROSCIENCE is
a Company that is engaged in the discovery, development and commercialization of innovative therapeutic approaches designed
to treat pediatric and adult neurological disorders such as Autism, ADD, Stroke and Brain Injury. The Company believes that
its efforts may deliver proprietary next-generation therapies, such as multisensory stimulation therapies, neuromodulation
therapies and multisensory processing research. These therapeutic approaches are directed toward changing
the way that the brain processes sensory information.
To speak with a company representative, please email a request for information.
Contact the Company